A recent comparative study in the New England Journal of Medicine reports on the benefits of Dolutegravir in pregnancy compared to other HIV regimens currently used in the United States.
Patel K, Huo Y, Jao J, et al. Dolutegravir in pregnancy as compared with current HIV regimens in the United States. N Engl J Med. 2022 Sep 1;387(9):799-809.
Article (subscription may be required)